Published in Biochem J on April 01, 1971
Thymidine kinase of mouse spleen cells in vivo and in vitro. Biochem J (1975) 0.75
Protein measurement with the Folin phenol reagent. J Biol Chem (1951) 1743.91
Isolation of pure and unaltered liver nuclei morphology and biochemical composition. Exp Cell Res (1956) 5.68
REGENERATION OF MAMMALIAN LIVER. Int Rev Cytol (1963) 5.34
Variations in phosphokinase activities during the cell cycle in synchronous populations of HeLa cells. Nature (1965) 1.61
Studies on the development, biochemistry, and biology of experimental hepatomas. Adv Cancer Res (1965) 1.54
Origin of the thymidine kinase induced by polyoma virus in productively infected cells. J Virol (1969) 1.41
Properties of deoxythymidine kinase partially purified from animal tumors. J Biol Chem (1965) 1.20
Thymidine kinase in rat liver during development. Biochem J (1968) 1.16
END-PRODUCT INHIBITION OF THYMIDINE KINASE ACTIVITY IN NORMAL AND LEUKEMIC HUMAN LEUKOCYTES. Cancer Res (1964) 1.06
Electrophoresis of adenovirus-specified thymidine kinase. J Virol (1969) 0.85
Activation of thymidine kinase of adult rat liver by the culture filtrate of Clostridium perfringens. Biochim Biophys Acta (1970) 0.84
Studies on the intracellular distribution of thymidine phosphorylating kinase activities in regenerating rat liver. Eur J Biochem (1968) 0.83
Purification of the factor involved in thymidine phosphorylation in adult rat liver. Biochim Biophys Acta (1970) 0.80
The regulation of rat liver xanthine oxidase. Involvement of thiol groups in the conversion of the enzyme activity from dehydrogenase (type D) into oxidase (type O) and purification of the enzyme. Biochem J (1972) 3.29
Ribosome-inactivating proteins from plants. Biochim Biophys Acta (1993) 2.97
CD30 (Ki-1) molecule: a new cytokine receptor of the tumor necrosis factor receptor superfamily as a tool for diagnosis and immunotherapy. Blood (1995) 2.67
The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type O). J Biol Chem (1969) 2.65
Studies on the pathogenesis of liver necrosis by alpha-amanitin. Effect of alpha-amanitin on ribonucleic acid synthesis and on ribonucleic acid polymerase in mouse liver nuclei. Biochem J (1967) 2.24
Gelonin, a new inhibitor of protein synthesis, nontoxic to intact cells. Isolation, characterization, and preparation of cytotoxic complexes with concanavalin A. J Biol Chem (1980) 2.16
Human immune response to cytomegalovirus structural polypeptides studied by immunoblotting. J Med Virol (1985) 2.09
Inhibition by ricin of protein synthesis in vitro. Ribosomes as the target of the toxin. Biochem J (1973) 1.72
Ribosome-inactivating proteins up to date. FEBS Lett (1986) 1.70
Simultaneous assay of RNA polymerase I and II in nuclei isolated from resting and growing rat liver with the use of alpha-amanitin. FEBS Lett (1970) 1.67
Fructose-induced hyperuricaemia. Lancet (1970) 1.66
Regulation of rat liver pyruvate kinase. The effect of preincubation, pH, copper ions, fructose 1,6-diphosphate and dietary changes on enzyme activity. Biochem J (1968) 1.60
The regulation of xanthine oxidase. Inhibition by reduced nicotinamide-adenine dinucleotide of rat liver xanthine oxidase type D and of chick liver xanthine dehydrogenase. Biochem J (1970) 1.56
Inhibition by ricin of protein synthesis in vitro. Inhibition of the binding of elongation factor 2 and of adenosine diphosphate-ribosylated elongation factor 2 to ribosomes. Biochem J (1975) 1.53
Polynucleotide:adenosine glycosidase activity of ribosome-inactivating proteins: effect on DNA, RNA and poly(A). Nucleic Acids Res (1997) 1.51
Modeccin, the toxin of Adenia digitata. Purification, toxicity and inhibition of protein synthesis in vitro. Biochem J (1978) 1.46
Serum specific IgA antibody to Chlamydia trachomatis in patients with chlamydial infections detected by ELISA and an immunofluorescence test. J Clin Pathol (1984) 1.46
Decreased RNA content in mouse liver nuclei after intoxication with alpha-amanitin. Biochim Biophys Acta (1966) 1.45
Selective inhibition of a nuclear RNA polymerase in cells infected with frog virus. Nature (1970) 1.44
Inhibition by ricin of protein synthesis in vitro: 60 S ribosomal subunit as the target of the toxin. Biochem J (1973) 1.42
Parvovirus b19 DNA is commonly harboured in human skin. Dermatology (2010) 1.41
Acute depression from isotretinoin. Another case. J Eur Acad Dermatol Venereol (2005) 1.38
Inhibition by alpha-amanitin of ribonucleic acid polymerase solubilized from rat liver nuclei. Biochem J (1970) 1.38
An immunotoxin composed of monoclonal anti-Thy 1.1 antibody and a ribosome-inactivating protein from Saponaria officinalis: potent antitumor effects in vitro and in vivo. J Natl Cancer Inst (1985) 1.37
Xanthine oxidase type D (dehydrogenase) in the intestine and other organs of the rat. Biochem J (1972) 1.35
Inhibition of protein synthesis in vitro by proteins from the seeds of Momordica charantia (bitter pear melon). Biochem J (1980) 1.35
Studies in Mediterranean leishmaniasis. 3. The leishmanin skin test in kala-azar. Trans R Soc Trop Med Hyg (1975) 1.29
Experimental conditions affecting ribonucleic acid polymerase in isolated rat liver nuclei. Effect of nucleoside triphosphate concentration, temperature, ammonium sulphate and heparin. Biochem J (1969) 1.27
Identification and preliminary use of recombinant lambda gt11 fusion proteins in human cytomegalovirus diagnosis. J Gen Virol (1989) 1.26
Mistletoe toxicity. Lancet (1983) 1.24
Purification and partial characterization of another form of the antiviral protein from the seeds of Phytolacca americana L. (pokeweed). Biochem J (1982) 1.24
Inhibition of protein synthesis by modeccin, the toxin of Modecca digitata. FEBS Lett (1977) 1.20
Antibody response to recombinant lambda gt11 fusion proteins in cytomegalovirus infection. J Clin Microbiol (1989) 1.20
Dianthins, ribosome-damaging proteins with anti-viral properties from Dianthus caryophyllus L. (carnation). Biochem J (1981) 1.18
Chlamydial infections in Italy. Sex Transm Dis (1982) 1.18
Effect of modeccin on the steps of peptide-chain elongation. Biochem J (1978) 1.17
Partial characterization of an 89-kDa highly immunoreactive protein from Chlamydia psittaci A/22 causing ovine abortion. FEMS Microbiol Lett (1991) 1.16
The regulation of rat-liver xanthine oxidase: Activation by proteolytic enzymes. FEBS Lett (1968) 1.16
Cytotoxicity acquired by conjugation of an anti-Thy1.1 monoclonal antibody and the ribosome-inactivating protein, gelonin. Eur J Biochem (1981) 1.15
Inhibition of protein synthesis by seed-extracts. A screening study. FEBS Lett (1977) 1.14
Studies on the proteins from the seeds of Croton tiglium and of Jatropha curcas. Toxic properties and inhibition of protein synthesis in vitro. Biochem J (1976) 1.14
Serum antibodies to individual cytomegalovirus structural polypeptides in renal transplant recipients during viral infection. Microbiol Immunol (1986) 1.12
Inhibition of protein synthesis in vitro by crotins and ricin. Effect on the steps of peptide chain elongation. Biochem J (1976) 1.12
Prevalence in Italy of antibodies to a new human papovavirus (BK virus). J Med Microbiol (1974) 1.11
Properties of the xanthine oxidase from human liver. Biochim Biophys Acta (1969) 1.11
Inhibition of protein synthesis in vitro by a lectin from Momordica charantia and by other haemagglutinins. Biochem J (1979) 1.11
Human immunodeficiency virus type 1 Tat protein protects lymphoid, epithelial, and neuronal cell lines from death by apoptosis. Cancer Res (1993) 1.11
Effect of ribosome-inactivating proteins on virus-infected cells. Inhibition of virus multiplication and of protein synthesis. Arch Virol (1982) 1.10
Unexpected activity of saporins. Nature (1994) 1.10
An autocrine loop of HIV type-1 Tat protein responsible for the improved survival/proliferation capacity of permanently Tat-transfected cells and required for optimal HIV-1 LTR transactivating activity. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.10
Antibodies against full-length Tat protein and some low-molecular-weight Tat-peptides correlate with low or undetectable viral load in HIV-1 seropositive patients. J Clin Virol (2001) 1.08
Studies on mediterranean Leishmaniasis. I. An outbreak of visceral leishmaniasis in Northern Italy. Trans R Soc Trop Med Hyg (1974) 1.07
Distribution and properties of major ribosome-inactivating proteins (28 S rRNA N-glycosidases) of the plant Saponaria officinalis L. (Caryophyllaceae). Biochim Biophys Acta (1993) 1.07
Modification of the carbohydrate in ricin with metaperiodate-cyanoborohydride mixtures. Effects on toxicity and in vivo distribution. Eur J Biochem (1985) 1.07
Effect of antibody to HIV-1 Tat protein on viral replication in vitro and progression of HIV-1 disease in vivo. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.07
Regulation of xanthine oxidase in rat liver: modifications of the enzyme activity of rat liver supernatant on storage at 20 degrees. Biochem J (1968) 1.07
Ultrastructural aspects of BK virus uptake and replication in human fibroblasts. J Gen Virol (1975) 1.04
Evaluation of immunoassays for the detection and typing of PCR amplified human papillomavirus DNA. J Clin Pathol (1998) 1.04
Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis (1988) 1.02
Bispecific F(ab' gamma)2 antibody for the delivery of saporin in the treatment of lymphoma. J Immunol (1988) 1.02
Ribonucleic acid polymerase induced by vaccinia virus: lack of inhibition by rifampicin and alpha-amanitin. J Virol (1970) 1.01
Inhibition of protein synthesis by a toxic lectin from Viscum album L. (mistletoe). Biochem J (1980) 1.01
Regulation of xanthine dehydrogenase in chick liver. Further experiments on the effects of inosine, actinomycin D and other factors. Biochem J (1967) 1.00
Antigenic specificity of serological response in Chlamydia trachomatis urethritis detected by immunoblotting. J Clin Pathol (1986) 1.00
Induction of apoptosis by ribosome-inactivating proteins and related immunotoxins. Int J Cancer (1996) 0.99
Some ribosome-inactivating proteins depurinate ribosomal RNA at multiple sites. Biochem J (1992) 0.99
Toxic effects of ricin: studies on the pathogenesis of liver lesions. Virchows Arch B Cell Pathol (1976) 0.98
Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation (1995) 0.98
Bryodin, a ribosome-inactivating protein from the roots of Bryonia dioica L. (white bryony). Biochem J (1986) 0.98
Rapid screening for B19 parvovirus DNA in clinical specimens with a digoxigenin-labeled DNA hybridization probe. J Clin Microbiol (1990) 0.97
Enzyme-linked immunosorbent assay for the in-vitro detection of sensitivity of Chlamydia trachomatis to antimicrobial drugs. J Antimicrob Chemother (1987) 0.97
Polynucleotide: adenosine glycosidase activity of saporin-L1: effect on DNA, RNA and poly(A). Biochem J (1996) 0.97
Prevalence of enteric adenovirus from acute gastroenteritis: a five year study. Eur J Epidemiol (1987) 0.96
Tat-expressing Jurkat cells show an increased resistance to different apoptotic stimuli, including acute human immunodeficiency virus-type 1 (HIV-1) infection. Br J Haematol (1995) 0.96
Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis (1992) 0.96
Trichosanthin, alpha-momorcharin and beta-momorcharin: identity of abortifacient and ribosome-inactivating proteins. Int J Pept Protein Res (1988) 0.95
Inactivation of polykaryocytogenic and hemolytic activities of Sendai virus by phospholipase B (lysolecithinase). J Virol (1971) 0.95
Effect of heat shock on Epstein-Barr virus and cytomegalovirus expression. J Gen Virol (1985) 0.95
Impairment of cytomegalovirus and host balance in elderly subjects. J Clin Pathol (1988) 0.95
The formation of 2,3-dihydroxy-2,3-dihydro-aflatoxin B1 by the metabolism of aflatoxin B1 by liver microsomes isolated from certain avian and mammalian species and the possible role of this metabolite in the acute toxicity of aflatoxin B1. Toxicol Appl Pharmacol (1981) 0.95
Seed extracts inhibiting protein synthesis in vitro. Biochem J (1980) 0.94
A novel metronomic chemotherapy regimen of weekly platinum and daily oral etoposide in high-risk non-small cell lung cancer patients. Oncol Rep (2006) 0.94
Uninfected haematopoietic progenitor (CD34+) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS (1993) 0.94
Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe). J Biol Chem (1982) 0.94
A hybrido-immunocytochemical assay for the in situ detection of cytomegalovirus DNA using digoxigenin-labeled probes. J Immunol Methods (1989) 0.92
Recombinant human immunodeficiency virus type-1 (HIV-1) Tat protein sequentially up-regulates IL-6 and TGF-beta 1 mRNA expression and protein synthesis in peripheral blood monocytes. Br J Haematol (1994) 0.92
Action of viscumin, a toxic lectin from mistletoe, on cells in culture. J Biol Chem (1982) 0.92
[Research on the mechanism of cytopathogenic action of alpha-amanitine]. Sperimentale (1967) 0.92
Comparison of the immune response to Epstein-Barr virus and cytomegalovirus in sera and synovial fluids of patients with rheumatoid arthritis. Ann Rheum Dis (1987) 0.92
Impaired in vitro growth of purified (CD34+) hematopoietic progenitors in human immunodeficiency virus-1 seropositive thrombocytopenic individuals. Blood (1992) 0.92
Properties of the ribosome-inactivating proteins gelonin, Momordica charantia inhibitor, and dianthins. Biochem J (1982) 0.92
Studies on Mediterranean leishmaniasis. IV. The leishmanin skin test in cutaneous leishmaniasis. Trans R Soc Trop Med Hyg (1976) 0.92
The regulation of rat liver xanthine oxidase: conversion of type D (dehydrogenase) into type O (oxidase) by a thermolabile factor, and reversibility by dithioerythritol. Biochim Biophys Acta (1970) 0.92